SECsense Logo

Entero Therapeutics, Inc. 8-K Report: Key Insights & Financial Overview

$ENTO
Form 8-K
Filed on: 2025-01-13
Source
Entero Therapeutics, Inc. 8-K Report: Key Insights & Financial Overview

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Entero Therapeutics, Inc.
  • CIK (Central Index Key): 0001604191
  • IRS Employer Identification Number (EIN): 46-4993860
  • Address: 777 Yamato Road, Suite 502, Boca Raton, FL 33431
  • Contact Number: 561-589-7020
  • Public Trading Exchange: NASDAQ
  • Ticker Symbol: ENTO
  • Common Stock Par Value: $0.0001 per share
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 7, 2025
  1. Financial Context:
  • Reporting Date: The financial information is as of January 7, 2025.
  • Units of Measurement:
    • Currency: USD (United States Dollar)
    • Shares: Common stock shares
    • The report uses a division of USD by shares, indicating a per share metric.
  1. Regulatory Compliance: The report follows the XBRL (eXtensible Business Reporting Language) format, which is compliant with SEC requirements for electronic filing.
  2. Schema Reference: The document references an XSD schema file (fwbi-20250107.xsd), which defines the structure of the financial data reported.

This information provides a snapshot of Entero Therapeutics, Inc., covering essential aspects of its corporate identity, financial reporting obligations, and the nature of the filing.